Evidence map›Paper›PMID 37102889›Full record

ReviewGels (Basel, Switzerland)2023

Recent Development of Functional Chitosan-Based Hydrogels for Pharmaceutical and Biomedical Applications.

Siriporn Taokaew, Worasak Kaewkong, Worawut Kriangkrai

Open access · goldAbstract readReview
In one paragraph

Review in Gels (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
8.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Freeze-Dried CS/PVP/PVA Composite Scaffolds Doped with Curcumin and SiOInternational journal of molecular sciences · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Siriporn TaokaewDepartment of Materials Science and Bioengineering, School of Engineering, Nagaoka University of Technology, Nagaoka 940-2188, Japan.ORCID 0000-0003-2262-5178
Worasak KaewkongDepartment of Biochemistry, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand.ORCID 0000-0002-7130-5827
Worawut KriangkraiDepartment of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand.ORCID 0000-0001-9367-4343
Naresuan University · THNagaoka University of Technology · JP

Funding

Funds for the Development of Human Resources in Science and Technology "Initiative for the im-plementation of diversity research environment", the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), JapanGlobal and Frontier Research University Fund from Naresuan University R2566C053
6 · The paper itself

Abstract

Chitosan is a promising naturally derived polysaccharide to be used in hydrogel forms for pharmaceutical and biomedical applications. The multifunctional chitosan-based hydrogels have attractive properties such as the ability to encapsulate, carry, and release the drug, biocompatibility, biodegradability, and non-immunogenicity. In this review, the advanced functions of the chitosan-based hydrogels are summarized, with emphasis on fabrications and resultant properties reported in literature from the recent decade. The recent progress in the applications of drug delivery, tissue engineering, disease treatments, and biosensors are reviewed. Current challenges and future development direction of the chitosan-based hydrogels for pharmaceutical and biomedical applications are prospected.

Indexed as

biomedical applicationschitosancontrolled drug deliveryfabricationmultifunctional hydrogels

Identifiers

PMID37102889
PMCPMC10138304
OpenAlexW4361222640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.